CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy Director bought 277,895 shares at $2.97 ($825,348)
- 4 Open-market buy Director bought 500,000 shares at an average $2.98 ($1,492,385)
- 8-K/A Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market buy Director bought 172,189 shares at $2.90 ($500,089)
- UPLOAD Other SEC-generated Letter
- 4 Option exercise Director acquired 659,947 shares (option exercise)
- PRER14A Other PRER14A
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
Page 8 of 20 · 400 filings